FDA 483 - Uscom Limited - May 29, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Uscom Limited, a manufacturer of Class II medical devices in Sydney, Australia, revealed significant deficiencies in their quality management system. The firm failed to adequately document rework and reevaluation activities, including not following non-conformance procedures for out-of-calibration devices and leaving non-conformance reports open for extended periods. Additionally, the inspection found that quality audits were not conducted by qualified individuals as per the firm's own procedures.
ID · f28ff6f9-1a92-4a48-b3c6-89d19059259b